Clinical Trials Sponsored by Celgene
Total 1430 results
-
CelgeneBeiGeneTerminatedCarcinoma, Non-Small-Cell LungSpain, United States, Japan, China, Canada, United Kingdom, Belgium, Singapore, Korea, Republic of, Netherlands, France, Romania, Greece, Germany, Taiwan, Finland, Italy, Poland, Hungary, Ireland, Portugal, New Zealand, Russian Federation
-
CelgeneCelgene CorporationCompletedLymphoma | CancerUnited States, United Kingdom
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
Celgene CorporationTerminatedColorectal CancerAustralia, Belgium, Germany, Italy, Spain, Sweden
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States, Denmark, Australia, Belgium, Czech Republic, France, Germany, Greece, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom
-
Celgene CorporationCompletedMultiple MyelomaIreland, Spain, Australia, Austria, United Kingdom
-
Celgene CorporationCompletedSmall Cell Lung CancerUnited States
-
Celgene CorporationWithdrawnMetastatic Breast CancerUnited States
-
Celgene CorporationCompletedNeoplasms | FatigueUnited States
-
Celgene CorporationCompletedMyelodysplastic SyndromesUnited States
-
CelgeneCelgene CorporationCompletedGlioma | Solid Tumor | Angioimmunoblastic T-cell Lymphoma | Chondrosarcoma | Intrahepatic CholangiocarcinomaUnited States, France
-
CelgeneCelgene CorporationTerminatedAdvanced Solid TumorsUnited States
-
CelgeneCelgene CorporationCompletedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States, Australia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
Celgene CorporationTerminated
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Celgene CorporationTerminatedDiffuse Large B-cell LymphomaUnited States, Canada, Australia
-
Celgene CorporationCompletedComplex Regional Pain Syndrome (RSD)United States
-
Celgene CorporationCompletedGlioblastoma | Malignant GliomasUnited States
-
CelgeneCelgene CorporationCompletedCutaneous T-cell LymphomaUnited States, France, Germany, Poland, Russian Federation, United Kingdom
-
Celgene CorporationCompletedHealthy SubjectsUnited States
-
Celgene CorporationTerminatedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin LymphomaJapan
-
Celgene CorporationCompletedHealthy VolunteersUnited States
-
Celgene CorporationWithdrawn
-
Celgene CorporationTerminatedComplex Regional Pain Syndrome, Type IUnited States
-
Celgene CorporationUnknown
-
Celgene CorporationCompleted
-
Celgene CorporationCompletedRadiculopathyUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Celgene CorporationTerminatedMyeloid LeukemiaUnited States
-
Celgene CorporationCompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Prostate CancerUnited States
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
CelgeneNot yet recruiting
-
CelgeneNot yet recruitingLarge B-cell LymphomaUnited States, Canada, Argentina, Australia, Austria, Brazil, Bulgaria, Chile, China, Colombia, Croatia, Czechia, Denmark, Finland, France, Germany, Greece, Hungary, Japan, Korea, Republic of, Malaysia, Mexico, New Zealand, Norway, Poland, Portug... and more
-
CelgeneRecruitingMultiple MyelomaAustria, China, Australia, Spain, Canada, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Italy, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finla... and more
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
CelgeneRecruitingMultiple MyelomaUnited States, Germany, Canada, France, Greece, Italy, Spain, Denmark, Czechia
-
CelgeneRecruitingLymphoma, Non-HodgkinUnited States, Korea, Republic of, China, Canada, France, Spain, Denmark, Brazil, Argentina, Austria, Chile, Israel, Italy, United Kingdom, Belgium
-
CelgeneRecruitingMultiple MyelomaUnited States, Spain, Sweden, Germany, Italy, Japan
-
CelgeneRecruitingCrohn DiseaseUnited States, Australia, Argentina, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Korea, Republic of, Latvia, Mexico, Moldova, Republic of, Poland, Romani... and more
-
CelgeneRecruitingNeoplasmsUnited States, Austria, Belgium, Canada, France, Germany, Japan, Netherlands, Spain, Sweden, Italy, United Kingdom, Norway, Finland
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Primary MyelofibrosisUnited States, Puerto Rico
-
CelgeneActive, not recruitingSmall Cell Lung CarcinomaFrance, Italy, Spain
-
CelgeneTerminatedNeoplasms | Lymphoma, Non-HodgkinFrance, Italy, Japan, Spain, United Kingdom
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Italy, Canada, France, Germany, Netherlands, Spain
-
CelgeneActive, not recruitingGlioblastoma | AstrocytomaUnited States, Spain
-
CelgeneCompleted
-
CelgeneCompletedMultiple SclerosisUnited States, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Moldova, Republic of, New Zealand, Poland, Portugal, Romania, Serbia, Slovakia, South... and more